Compare GHRS & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GHRS | TTI |
|---|---|---|
| Founded | 2018 | 1981 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 1.1B |
| IPO Year | 2021 | 1996 |
| Metric | GHRS | TTI |
|---|---|---|
| Price | $27.60 | $10.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $41.38 | $10.40 |
| AVG Volume (30 Days) | 256.9K | ★ 1.5M |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.70 |
| Revenue Next Year | N/A | $11.35 |
| P/E Ratio | ★ N/A | $170.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.32 | $3.17 |
| 52 Week High | $25.94 | $12.54 |
| Indicator | GHRS | TTI |
|---|---|---|
| Relative Strength Index (RSI) | 73.23 | 56.90 |
| Support Level | $12.88 | $10.48 |
| Resistance Level | N/A | $10.86 |
| Average True Range (ATR) | 1.72 | 0.47 |
| MACD | 0.53 | -0.00 |
| Stochastic Oscillator | 95.38 | 85.21 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.